What is the share price of Camlin Fine Sciences Ltd (CAMLINFINE) today?
The share price of CAMLINFINE as on 9th July 2025 is ₹297. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Camlin Fine Sciences Ltd (CAMLINFINE) share?
The past returns of Camlin Fine Sciences Ltd (CAMLINFINE) share are- Past 1 week: -4.94%
- Past 1 month: 13.02%
- Past 3 months: 119.97%
- Past 6 months: 121.95%
- Past 1 year: 190.66%
- Past 3 years: 179.76%
- Past 5 years: 421.16%
What are the peers or stocks similar to Camlin Fine Sciences Ltd (CAMLINFINE)?
The peers or stocks similar to Camlin Fine Sciences Ltd (CAMLINFINE) include:What is the market cap of Camlin Fine Sciences Ltd (CAMLINFINE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Camlin Fine Sciences Ltd (CAMLINFINE) is ₹5616.96 Cr as of 9th July 2025.What is the 52 week high and low of Camlin Fine Sciences Ltd (CAMLINFINE) share?
The 52-week high of Camlin Fine Sciences Ltd (CAMLINFINE) is ₹333.30 and the 52-week low is ₹93.40.What is the PE and PB ratio of Camlin Fine Sciences Ltd (CAMLINFINE) stock?
The P/E (price-to-earnings) ratio of Camlin Fine Sciences Ltd (CAMLINFINE) is -40.40. The P/B (price-to-book) ratio is 6.55.Which sector does Camlin Fine Sciences Ltd (CAMLINFINE) belong to?
Camlin Fine Sciences Ltd (CAMLINFINE) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Camlin Fine Sciences Ltd (CAMLINFINE) shares?
You can directly buy Camlin Fine Sciences Ltd (CAMLINFINE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Camlin Fine Sciences Ltd
CAMLINFINE Share Price
297.000.64% (-1.90)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
CAMLINFINE Stock Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
CAMLINFINE Performance & Key Metrics
CAMLINFINE Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -40.40 | 6.55 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.96 | 3.49 | 1.57% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
CAMLINFINE Company Profile
Camlin Fine Sciences Limited is engaged in fine chemicals business. It provides antioxidants and shelf life extensions, aroma ingredients, performance chemical products and related solutions various industries.
FLUOROCHEM
PE Ratio
69.30
69.30
1Y Return
6.69%
6.69%
Buy Reco %
55.56
55.56
NAVINFLUOR
PE Ratio
86.61
86.61
1Y Return
37.57%
37.57%
Buy Reco %
61.54
61.54
VINATIORGA
PE Ratio
51.69
51.69
1Y Return
5.37%
5.37%
Buy Reco %
83.33
83.33
AKZOINDIA
PE Ratio
39.07
39.07
1Y Return
28.17%
28.17%
Buy Reco %
50.00
50.00
AARTIIND
PE Ratio
50.51
50.51
1Y Return
34.90%
34.90%
Buy Reco %
70.59
70.59
CAMLINFINE Sentiment Analysis
CAMLINFINE Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
CAMLINFINE Stock Summary · May 2025
In a challenging global environment marked by tariffs and geopolitical tensions, the company demonstrated resilience with satisfactory financial results, driven by strategic discontinuation of unviable operations in Europe and China. Despite facing price pressures, particularly in the vanillin market due to competition from Chinese manufacturers, the core blends segment showed significant year-on-year growth, bolstered by anticipated anti-dumping duties. However, low capacity utilization and high production costs remain concerns, prompting a cautious approach to investment and operational efficiency. Management is optimistic about future growth, particularly in the blends business, while navigating the complexities of pricing dynamics and inventory management in the vanillin sector. Overall, the outlook reflects a blend of cautious optimism and strategic adjustments aimed at enhancing profitability.
CAMLINFINE Stock Growth Drivers
CAMLINFINE Stock Growth Drivers
7Strong Financial Performance
Camlin Fine Sciences Limited reported a total turnover of INR 437 crores in the current
Strategic Business Adjustments
The company has officially discontinued operations related to two unviable manufacturing units in Europe and
CAMLINFINE Stock Challenges
CAMLINFINE Stock Challenges
6Discontinued Operations and Impairments
The company has recognized the abandonment of two unviable manufacturing units, leading to a complete
High Production Costs and Low Capacity Utilization
The cost of production for vanillin remains high at around $9 due to low capacity
CAMLINFINE Forecast
CAMLINFINE Forecasts
Price
Revenue
Earnings
CAMLINFINE Share Price Forecast
CAMLINFINE Share Price Forecast
2025
Current
₹298.90
Baseline
Forecast for Jul 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹298.90
Baseline
Forecast for Jul 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
CAMLINFINE Company Revenue Forecast
CAMLINFINE Company Revenue Forecast
2025
Current
₹1.68
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2025
Current
₹1.68
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
CAMLINFINE Stock EPS (Earnings Per Share) Forecast
CAMLINFINE Stock EPS (Earnings Per Share) Forecast
2025
Current
₹2.89
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹2.89
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
CAMLINFINE
CAMLINFINE
Income
Balance Sheet
Cash Flow
Annual Normal View
CAMLINFINE Income Statement
CAMLINFINE Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 548.46 | 732.33 | 905.96 | 1,052.58 | 1,192.08 | 1,445.12 | 1,687.36 | 1,628.62 | 1,681.42 | 1,714.49 | ||||||||||
Raw Materials | 294.26 | 424.79 | 495.45 | 553.17 | 566.17 | 772.90 | 916.28 | 860.87 | 1,675.75 | 1,698.91 | ||||||||||
| Power & Fuel Cost | 46.35 | 61.43 | 80.42 | 76.38 | 84.16 | 123.01 | 204.60 | 124.31 | ||||||||||||
| Employee Cost | 61.09 | 72.87 | 87.89 | 99.71 | 120.38 | 145.05 | 162.62 | 178.75 | ||||||||||||
| Selling & Administrative Expenses | 71.76 | 76.34 | 82.78 | 96.14 | 92.18 | 82.94 | 96.58 | 93.35 | ||||||||||||
| Operating & Other expenses | 28.63 | 69.17 | 72.78 | 88.54 | 137.33 | 130.48 | 98.15 | 322.01 | ||||||||||||
EBITDA | 46.37 | 27.73 | 86.64 | 138.64 | 191.86 | 190.74 | 209.13 | 49.33 | 5.67 | 15.58 | ||||||||||
| Depreciation/Amortization | 21.80 | 26.65 | 28.99 | 32.80 | 44.29 | 55.96 | 62.51 | 78.61 | 63.84 | 73.67 | ||||||||||
| PBIT | 24.57 | 1.08 | 57.65 | 105.84 | 147.57 | 134.78 | 146.62 | -29.28 | -58.17 | -58.09 | ||||||||||
| Interest & Other Items | 30.58 | 31.80 | 40.95 | 47.63 | 42.48 | 40.80 | 66.24 | 69.97 | 99.88 | 99.97 | ||||||||||
| PBT | -6.01 | -30.72 | 16.70 | 58.21 | 105.09 | 93.98 | 80.38 | -99.25 | -158.05 | -158.06 | ||||||||||
| Taxes & Other Items | 5.16 | -1.09 | 16.12 | 27.88 | 54.13 | 33.29 | 28.27 | -6.49 | -19.00 | -19.03 | ||||||||||
| Net Income | -11.17 | -29.63 | 0.58 | 30.33 | 50.96 | 60.69 | 52.11 | -92.76 | -139.05 | -139.03 | ||||||||||
| EPS | -1.09 | -2.57 | 0.05 | 2.44 | 4.00 | 4.17 | 3.24 | -5.58 | 2.89 | -8.11 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CAMLINFINE Company Updates
FY 2025FY 2025
Investor Presentation
May 23PDF
Feb 19PDF
Feb 14PDF
Nov 11PDF
CAMLINFINE Stock Peers
CAMLINFINE Past Performance & Peer Comparison
CAMLINFINE Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation-basic on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Camlin Fine Sciences Ltd | -40.40 | 6.55 | — |
| Gujarat Fluorochemicals Ltd | 69.30 | 6.37 | 0.09% |
| Navin Fluorine International Ltd | 86.61 | 10.49 | 0.24% |
| Vinati Organics Ltd | 51.69 | 8.51 | 0.37% |
CAMLINFINE Stock Price Comparison
Compare CAMLINFINE with any stock or ETFCompare CAMLINFINE with any stock or ETF
CAMLINFINE
CAMLINFINE Holdings
CAMLINFINE Shareholdings
CAMLINFINE Promoter Holdings Trend
CAMLINFINE Promoter Holdings Trend
Increased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 1.07%
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
CAMLINFINE Institutional Holdings Trend
CAMLINFINE Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 3.12%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
CAMLINFINE Shareholding Pattern
CAMLINFINE Shareholding Pattern
CAMLINFINE Shareholding History
CAMLINFINE Shareholding History
Mutual Funds
Mutual Funds Invested in CAMLINFINE
Mutual Funds Invested in CAMLINFINE
No mutual funds holding trends are available
Top 5 Mutual Funds holding Camlin Fine Sciences Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6451% | Percentage of the fund’s portfolio invested in the stock 1.32% | Change in the portfolio weight of the stock over the last 3 months 0.42% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 24/58 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3378% | Percentage of the fund’s portfolio invested in the stock 2.31% | Change in the portfolio weight of the stock over the last 3 months 0.71% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 52/87 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.3314% | Percentage of the fund’s portfolio invested in the stock 2.58% | Change in the portfolio weight of the stock over the last 3 months 0.50% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 40/74 (+3) |
Compare 3-month MF holding change on Screener
smallcases containing CAMLINFINE stock
smallcases containing CAMLINFINE stock
Looks like this stock is not in any smallcase yet.
CAMLINFINE Events
CAMLINFINE Events
CAMLINFINE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CAMLINFINE has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CAMLINFINE Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CAMLINFINE has not given any dividends in last 5 years
CAMLINFINE Upcoming Dividends
CAMLINFINE Upcoming Dividends
No upcoming dividends are available
CAMLINFINE Past Dividends
CAMLINFINE Past Dividends
Cash Dividend
Ex DateEx DateJul 28, 2016
Final
Final | Div/Share: ₹0.45
Dividend/Share
₹0.45
Ex DateEx Date
Jul 28, 2016
Cash Dividend
Ex DateEx DateJul 27, 2015
Final
Final | Div/Share: ₹0.45
Dividend/Share
₹0.45
Ex DateEx Date
Jul 27, 2015
Cash Dividend
Ex DateEx DateJul 24, 2014
Final
Final | Div/Share: ₹0.70
Dividend/Share
₹0.70
Ex DateEx Date
Jul 24, 2014
Cash Dividend
Ex DateEx DateAug 1, 2013
Final
Final | Div/Share: ₹0.60
Dividend/Share
₹0.60
Ex DateEx Date
Aug 1, 2013
Cash Dividend
Ex DateEx DateJul 23, 2012
Final
Final | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Jul 23, 2012
CAMLINFINE Stock News & Opinions
CAMLINFINE Stock News & Opinions
Articles & Videos
Corporate
Camlin Fine Sciences AGM scheduled
Camlin Fine Sciences announced that the 32th Annual General Meeting(AGM) of the company will be held on 8 August 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Camlin Fine Sciences reports consolidated net loss of Rs 0.72 crore in the March 2025 quarter
Net Loss of Camlin Fine Sciences reported to Rs 0.72 crore in the quarter ended March 2025 as against net loss of Rs 77.14 crore during the previous quarter ended March 2024. Sales rose 16.14% to Rs 437.46 crore in the quarter ended March 2025 as against Rs 376.65 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 139.05 crore in the year ended March 2025 as against net loss of Rs 92.75 crore during the previous year ended March 2024. Sales rose 14.62% to Rs 1666.53 crore in the year ended March 2025 as against Rs 1453.91 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales437.46376.65 16 1666.531453.91 15 OPM %13.588.36 -12.4910.98 - PBDT54.6821.11 159 123.13114.95 7 PBT36.297.74 369 59.2958.59 1 NP-0.72-77.14 99 -139.05-92.75 -50 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Camlin Fine Sciences to announce Quarterly Result
Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 23 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Camlin Fine Sciences reports consolidated net loss of Rs 4.14 crore in the December 2024 quarter
Net Loss of Camlin Fine Sciences reported to Rs 4.14 crore in the quarter ended December 2024 as against net loss of Rs 11.79 crore during the previous quarter ended December 2023. Sales rose 12.34% to Rs 433.49 crore in the quarter ended December 2024 as against Rs 385.89 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales433.49385.89 12 OPM %10.836.05 - PBDT14.1510.85 30 PBT-0.33-9.73 97 NP-4.14-11.79 65 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Camlin Fine Sciences to conduct board meeting
Camlin Fine Sciences will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Camlin Fine Sciences appoints director
Camlin Fine Sciences has appointed Abeezar Faizullabhoy (DIN: 00264422) as an Additional Non-Executive Independent Director of the Company for the first term of 5 (five) years with effect from 04 February 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Camlin Fine Sciences resumes operations at its Dahej unit
Camlin Fine Sciences announced that the Gujarat Pollution Control Board (GPCB) has revoked its closure directive for the company's units at Dahej. The revocation order was issued following an inspection of the unit by the concerned authorities of GPCB on 23 January 2025. Consequently, the manufacturing operations at the unit will continue as normal. Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Camlin Fine Sciences allots 2.04 cr equity shares under rights issue
Camlin Fine Sciences has allotted 2,04,25,805 equity shares at an issue price of Rs 110 per equity share (including premium of Rs 109 per equity share) to eligible equity shareholders pursuant to the rights issue. Accordingly, the paid-up equity share capital of the company has increased from Rs 16,74,95,207 to Rs 18,79,21,012 by addition of 2,04,25,805 equity shares.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Camlin Fine Sciences receives pollution control board directive to close unit in Dahej SEZ
Camlin Fine Sciences has received order dated 17 January 2025 from Gujarat Pollution Control Board issuing closure directions under Section 33']A of the Water (Prevention and Control of Pollution) Act']1974, as amended from time to time (Directions) for the Company'fs unit situated at Plot No. Z/96/D, Part'] II, Dahej SEZ, Tal. Vagra, Dist. Bharuch. It is pertinent to note that as of date, the Company has addressed and complied with the alleged non']compliances mentioned in the Directions. This has been communicated to the relevant authority, along with the necessary supporting documents. Additionally, the Company has initiated steps to seek revocation of the Directions before they take effect, which is set for 15 days after 17 January 2025. Given these facts and circumstances, the Company does not anticipate any impact on the plant's production.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Camlin Fine Sciences fixes record date for rights issue
Camlin Fine Sciences has fixed 08 January 2024 as record date for rights issue. Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 9.82%, vs industry avg of 11.07%
Over the last 5 years, market share decreased from 1.97% to 1.77%